Skip to Main Content

Paper Details

A Cross-Comparison of High-Throughput Platforms for Circulating MicroRNA Quantification, Agreement in Risk Classification, and Biomarker Discovery in Non-Small Cell Lung Cancer.
Front Oncol
2
2022
Author NameAffiliation
Loris De CeccoFondazione IRCCS Istituto Nazionale dei Tumori
  • 1 - 1

Datasets

Release 1.2